Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.72
-0.2400-3.02%
Post-market: 7.950.2300+2.98%17:02 EDT
Volume:18.85K
Turnover:148.25K
Market Cap:52.46M
PE:-0.68
High:8.07
Open:7.93
Low:7.60
Close:7.96
Loading ...
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 08, 2023

Major Issues Report

8-K - Current report
Feb 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 18, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report